• SENSEX 76,594.51
    570.00 (+0.75%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Dr Lal Pathlabs
    2,494.00 3,645.00(%)
  • Kalyan Jewellers
    514.00 794.60(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    211.40 304.50(%)
  • SRF
    2,986.20 3,074.95(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • SpiceJet
    46.10 79.90(%)
  • Mazagon Dock
    2,601.00 2,929.98(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Suzlon Energy
    57.08 86.04(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Adani Green
    944.45 2,173.65(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,627.00 1,891.30(%)
  • Tata Motors
    662.00 606.20(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gland Pharma Ltd Pharmaceuticals - Indian - Formulations

  • MNC Associate
  • BSE Code : 14546.0
  • ISIN : INE068V01023
1,553.55 -39 (-2.44%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    1,548.40

  • Today’s High

    1,613.40

  • Open

    1,605.55

  • Perv Close

    1,592.40

  • 52W Low

    1,411.10

  • 52W High

    2,220.95

Key Indicators

  • P/E(TTM)

    22.85

  • Mar.Cap (₹Cr.)

    25,595.73

  • Div & Yield %

    1.29

  • Book Value(₹)

    556.81

  • Debt-Equity Ratio

    -2.44

  • AGM Date

    01-Apr-2025

  • EPS

    68.05

  • P/E Ratio

    22.85

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    25,595.73

  • RONW (%)

    9.26

  • ROCE (%)

    13.44

Score Board

  • Equity (₹ in Cr.)

    16.48

  • BV (₹)

    556.80

  • Sales( ₹ in Cr.)

    4,167.43

  • NP (in Cr.)

    1,043.71

  • NP Var(%)

    28.0

  • Div%

    2000.0

  • CPS (₹)

    73.20

  • EPS (₹)

    63.30

  • Traded Value (₹ in Lakhs)

    25,620.45

  • 52 Week High

    2,220.95

  • 52 Week Low

    1,411.10

  • Price BSE

    1555.0

  • Price NSE

    1,554.00

  • Market Capital( in Cr.)

    25,620.45

  • P/C Ratio

    21.20

  • P/E Ratio

    24.50

  • Price Vs.BV

    63.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24 2,044.20
Excise Duty 3,662.55 3,264.35 3,969.99 3,131.45 2,321.96 1,781.29
Net Sales 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24 2,044.20
Other Income 166.67 240.46 223.94 134.78 139.17 85.56
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 4,334.09 3,856.99 4,624.65 3,597.65 2,772.41 2,129.77
EXPENDITURE :
Raw Materials 3,662.55 3,264.35 3,969.99 3,131.45 2,321.96 1,781.29
Power & Fuel Cost 3,662.55 3,264.35 3,969.99 3,131.45 2,321.96 1,781.29
Employee Cost 409.95 399.70 338.57 311.36 277.66 222.95
Other Manufacturing Expenses 48.31 44.53 32.61 23.51 18.82 15.86
Selling & Administrative Expenses 175.97 189.65 177.43 128.44 98.54 82.52
Miscellaneous Expenses 48.31 44.53 32.61 23.51 18.82 15.86
Less : Pre-operative Expenses Capitalised :
Total Expenditure 2,928.60 2,752.13 3,005.61 2,262.80 1,779.54 1,423.41
Operating Profit 304.12 278.67 232.25 205.43 180.73 159.54
Interest 7.84 7.41 5.24 3.41 7.18 3.56
Gross Profit 1,405.50 1,048.40 1,619.04 1,334.85 992.87 686.36
Depreciation 162.11 146.74 110.30 98.78 94.59 81.96
Profit Before Tax 1,405.50 1,048.40 1,619.04 1,334.85 992.87 686.36
Tax 341.02 276.19 395.88 339.45 251.40 221.23
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 24.68 -2.80 14.01 0.12 -31.82 12.00
Reported Net Profit 1,043.33 775.83 1,212.16 997.01 772.86 451.91
Extraordinary Items 1,405.50 1,048.40 1,619.04 1,334.85 992.87 686.36
Adjusted Net Profit 1,043.33 775.83 1,212.16 997.01 772.86 451.91
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 329.42 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 1,043.33 775.83 1,212.16 997.01 772.86 451.91
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 2,000.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 20.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 63.35 47.12 73.84 63.07 49.88 29.16
Book Value 329.42 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 329.42 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    51.83%

  • Public Share Holding

    48.17%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 85,393,934 51.83 85,393,934 5
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 85,393,934 51.83 85,393,934 5
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 100 0.00 100 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,100 0.00 1,100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,301,342 5.04 8,301,342 149
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,267,301 1.38 2,267,301 8
Mutual Funds / UTI 53,324,746 32.37 53,324,746 22
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,734,302 1.05 1,734,302 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 65,628,891 39.84 65,628,891 193
2] Non Institution
Bodies Corporate 7,761,043 4.71 1,761,043 475
Clearing Members 166 0.00 166 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 362,509 0.22 362,509 2,127
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 120,805 0.07 120,805 1,723
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,000,000 0.61 1,000,000 1
Individuals holding nominal share capital up to Rs. 1 lakh 4,432,892 2.69 4,432,892 116,479
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,159 0.00 5,159 2
Others 0 0.00 0 0
Sub Total 13,728,898 8.33 7,728,898 120,877
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 164,751,723 100.00 158,751,723 121,075

Company Background

Gland Pharma LtdPharmaceuticals - Indian - Formulations

  • Gland Pharma Ltd
  • BSE Code : 14546.0
  • ISIN : INE068V01023

  • Incorporation Year

    1978

  • Registered Office

    Sy No 143-148 150&151 Nr Gandi
    X Roads D P Pally Dundigal, Hyderabad,
    Telangana-500043

  • Telephone

    91-40-30510999

  • FAX

    91-40-30510800

  • Chairman

    Yiu Kwan Stanley Lau

  • Managing Director

    SRINIVAS SADU

  • Company Secretary

  • Auditor

    Deloitte Haskins & Sells

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gland Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gland Pharma 1,555.05 4,334.09 4,167.43 22.85 16.65
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92